ArticleESC heart failure2024
Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome.
Andrea Kallmeyer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it